Profilo
Karen Eaton was the founder of Sigma Genetics, Inc. (founded in 2016) where she held the title of Chief Executive Officer from 2016 to 2017.
She is currently working as a Venture Partner at Pioneer Fund since 2022.
Ms. Eaton has an MBA and a doctorate from the University of Washington.
Posizioni attive di Karen Eaton
| Società | Posizione | Inizio |
|---|---|---|
Pioneer Fund/NY/
Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund invests in companies located across the globe. The firm targets companies operating in the fields of biotechnology, healthcare and life sciences sectors. It provides financing for seed and early stage capital requirements. | Investitore di Private Equity | 01/01/2022 |
Precedenti posizioni note di Karen Eaton
| Società | Posizione | Fine |
|---|---|---|
Sigma Genetics, Inc.
Sigma Genetics, Inc. Medical SpecialtiesHealth Technology Manufactures non-invasive devices | Amministratore Delegato | 01/10/2017 |
Formazione di Karen Eaton
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pioneer Fund/NY/
Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund invests in companies located across the globe. The firm targets companies operating in the fields of biotechnology, healthcare and life sciences sectors. It provides financing for seed and early stage capital requirements. | Finance |
Sigma Genetics, Inc.
Sigma Genetics, Inc. Medical SpecialtiesHealth Technology Manufactures non-invasive devices | Health Technology |
















